# Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults

> **NCT07422233** · PHASE4 · COMPLETED · sponsor: **Nasim Tabrizi** · enrollment: 137 (actual)

## Conditions studied

- Epilepsy
- Elderly

## Interventions

- **DRUG:** Oral levetiracetam

## Key facts

- **NCT ID:** NCT07422233
- **Lead sponsor:** Nasim Tabrizi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-13
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-20
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422233, "Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07422233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*